Suchergebnisse - "Held, Gerhard"

PubPharm (167)

11

Radiation and dose-densification of R-CHOP in primary mediastinal B-cell lymphoma : subgroup analysis of the UNFOLDER trial

enthalten in: HemaSphere | July 2023

von Held, G. | Thurner, L. | Poeschel, V. | +30

12

The new German evidence-based guideline on diffuse large B-cell lymphoma-key aspects for radiation oncologists

enthalten in: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al | 2023

von Oertel, M. | Berdel, C. | Held, G. | +6

13

The new German evidence-based guideline on diffuse large B-cell lymphoma—key aspects for radiation oncologists

enthalten in: Strahlentherapie und Onkologie | 2023

von Oertel, M. | Berdel, C. | Held, G. | +6

14

The new German evidence-based guideline on diffuse large B-cell lymphoma—key aspects for radiation oncologists

enthalten in: Strahlentherapie und Onkologie | 2023

von Oertel, M. | Berdel, C. | Held, G. | +6

15

Intensified cytarabine dose during consolidation in AML patients under 65 years is not associated with survival benefit: real-world data from the German SAL-AML registry

enthalten in: ResearchSquare.com | 2022

von Hanoun, M. | Ruhnke, L. | Kramer, M. | +30

16

Addition of isatuximab to lenalidomide, bortezomib, and dexamethasone as induction therapy for newly diagnosed, transplantation-eligible patients with multiple myeloma (GMMG-HD7) : part 1 of an open-label, multicentre, randomised, active-controlled, phase 3 trial

enthalten in: The Lancet. Haematology | 2022

von Goldschmidt, H. | Mai, E. | Bertsch, U. | +123

CommentIn: Lancet Haematol. 2022 Nov;9(11):e798-e799. - PMID 36328036

17

Intensified cytarabine dose during consolidation in adult AML patients under 65 years is not associated with survival benefit: real-world data from the German SAL-AML registry

enthalten in: Journal of cancer research and clinical oncology | 2022

von Hanoun, M. | Ruhnke, L. | Kramer, M. | +30

18

Intensified cytarabine dose during consolidation in adult AML patients under 65 years is not associated with survival benefit: real-world data from the German SAL-AML registry

enthalten in: Journal of cancer research and clinical oncology | 2022

von Hanoun, M. | Ruhnke, L. | Kramer, M. | +30

19

Intensified cytarabine dose during consolidation in adult AML patients under 65 years is not associated with survival benefit: real-world data from the German SAL-AML registry

enthalten in: Journal of cancer research and clinical oncology | 2022

von Hanoun, M. | Ruhnke, L. | Kramer, M. | +30

20

Central nervous system relapse in younger patients with diffuse large B-cell lymphoma - a LYSA and GLA/ DSHNHL analysis

enthalten in: ResearchSquare.com | 2022

von Thieblemont, C. | Altmann, B. | Frontzek, F. | +19